Ophthalmic technology developer Intalight has received the CE mark for its DREAM OCT [optical coherence tomography] platform, allowing the company to commercialise it within the European Union (EU).
Intalight noted that with its ultrawide field single scan, the platform provides a comprehensive 130° OCT angiography (OCTA) image.
Go deeper with GlobalData
Discover B2B Marketing That Performs
Combine business intelligence and editorial excellence to reach engaged professionals across 36 leading media platforms.
The device’s swept-source 12mm super-depth scanning offers visualisation of the choroid, retina, and a significant portion of the vitreous space.
Its anterior scanning capabilities also enable a complete view of the segment in a single scan, measuring 16.2mm in air.
Intalight’s DREAM OCT leverages ultra-wide swept-source technology to cater to the specific needs of retina specialists and ophthalmologists.
It has a scanning speed of up to 400KHz, essential for high-resolution OCTA, removing artefacts caused by eye movements.
US Tariffs are shifting - will you react or anticipate?
Don’t let policy changes catch you off guard. Stay proactive with real-time data and expert analysis.
By GlobalDataThe platform is also said to be capable of covering a field of 26mm × 21mm on the retina with a single scan, and an automatic montage can expand the range further to 200°, revealing lesions towards the retina’s edge.
According to the company, DREAM OCT can identify minute vascular pathologies, upholding a low false-positive rate.
Additional features such as 3D Projection Artefact Removal and Deep Layer algorithms minimise artefacts.
Intalight co-founder and CEO Bing Li said: “Over the past few years, we’ve heard from eye care professionals that they need a solution that gets them over the imaging finish line with speed, accuracy, and depth.
“DREAM OCT delivers a full set of imaging modalities for the most challenging clinical and research applications for the retina and outperforms everything else HCPs know.”
